This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Discrimination of idiopathic inflammatory myopathy (IIM) from other muscle diseases is at times difficult in clinical practice even after muscle biopsy.1
Acknowledgments
Acknowledgment: The authors thank Hiromi Yamaguchi (Department of Immunology, National Institute of Neuroscience [NIN], NCNP), Kanako Goto (Department of Neuromuscular Research, NIN, NCNP), and Dr. Shigeaki Suzuki (Department of Neurology, Keio University School of Medicine) for support.
Footnotes
Supplemental data at Neurology.org
Author contributions: A.U. was involved in the conceptualization and design of the study, data analysis and interpretation, literature review, and drafting the manuscript. S.N., W.S., H.N., and S.M. were involved in technical or material support, data interpretation, and manuscript revision for intellectual content. T.Y. was involved in the supervision of data analysis and interpretation and manuscript revision for intellectual content. I.N. was involved in the supervision of all aspects, including study design and data analysis and interpretation, and manuscript revision for intellectual content.
Study funding: Supported by JSPS KAKENHI (26860679, 25461323, and 26293214), Intramural Research Grant (26-8 and 23-5) for Neurological and Psychiatric Disorders of NCNP, and the Health and Labour Sciences Research Grants on Research on Development of New Drugs from the Ministry of Health, Labour and Welfare of Japan.
Disclosure: A. Uruha reports a grant from JSPS KAKENHI, grant number 26860679. S. Noguchi, W. Sato, H. Nishimura, S. Mitsuhashi, and T. Yamamura report no disclosures relevant to the manuscript. I. Nishino reports grants from Intramural Research Grant (23-5 and 26-8) for Neurological and Psychiatric Disorders of NCNP; JSPS KAKENHI, grant number 26293214; and research grants on rare and intractable diseases from the Ministry of Health, Labour, and Welfare. Go to Neurology.org for full disclosures.
- Received January 7, 2015.
- Accepted in final form March 18, 2015.
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
